Trials / Completed
CompletedNCT02629705
Study of Carrageenan's Effect on Insulin Resistance in Humans
Investigation of the Effect of Carrageenan as Food Additive on Insulin Resistance in Humans
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- University Hospital Tuebingen · Academic / Other
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether the ingestion of the common food additive carrageenan contributes to insulin resistance and thus to the pathogenesis of type 2 diabetes in humans.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Carrageenan | Carrageenan 250 mg bid supplemented to a standard food |
| DIETARY_SUPPLEMENT | Placebo | Placebo (Mannitol/Aerosil) bid supplemented to a standard food |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2016-12-23
- Completion
- 2018-02-01
- First posted
- 2015-12-14
- Last updated
- 2018-10-18
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02629705. Inclusion in this directory is not an endorsement.